Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread

Multiple Cancer Types

The objective of this study is to evaluate the efficacy and safety of sacituzumab govitecan-hziy monotherapy and with novel combinations in participants with metastatic urothelial cancer (mUC).
Bladder, Urologic
II
Davis, Nancy
NCT03547973
VICCURO18120

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: